Literature DB >> 8669367

Acceleration and timing of fertile ovulation in cyclic mares with a deslorelin implant.

A Gånheim1, A Gånheim1, W Jöchle.   

Abstract

In a blinded trial, the effectiveness and safety of 2.2 mg of the GnRH analog deslorelin acetate, administered in a short-term implant (STI) to normally cycling mares in estrus with a dominant ovarian follicle of 30 mm in diameter or larger, were evaluated, using a placebo implant as a negative control. A total of 39 mares received treatments at admittance with pre-randomized implants containing either 2.2 mg or 0 mg deslorelin. Mares were teased daily and examined rectally with ultrasound at 24 h intervals to determine time to ovulation and duration of estrus. The number of breedings and the pregnancy rate at 18 (+/- 3) and 38 (+/- 3) days were recorded, as were systemic side effects and local reactions at the implantation sites. Pregnancies resulting from breedings during the treatment estrus and/or from breedings during the next estrus were followed and the early and late pregnancy loss rate, the number of pregnancies going to term and of live-born foals was recorded. Mean follicle diameter at treatment was not significantly different between the deslorelin and placebo treatment group with 41.6 mm and 40.8 mm, respectively. Treatment with deslorelin STI reduced the time interval to ovulation significantly from 69.5 +/- 25.48 h to 42.7 +/- 12.35 h (p < 0.001). The percentage of mares having ovulated within 48 h rose from 26.3% to 95.0%, respectively, for placebo and deslorelin STI (p < 0.001). As a consequence, the duration of estrus in days and the percent of animals requiring more than 1 breeding were significantly reduced in deslorelin treated animals from 5.4 days to 4.6 days, and from 55.6% to 5.0%, respectively (p = 0.009 and = 0.001). The percent of mares pregnant from breedings at the treatment estrus (65.0% versus 44.4%) or the next estrus (83.3% versus 92.3%) was satisfactory and similar for deslorelin and placebo treated mares (p > 0.005), and in 70.0% and 66.7% of these once or twice bred mares did pregnancies go to term and live foals were born.

Mesh:

Substances:

Year:  1995        PMID: 8669367      PMCID: PMC8095403     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  10 in total

1.  Efficacy of a prostaglandin analogue in reproduction in the anestrous mare.

Authors:  D R Lamond; J R Buell; W S Stevenson
Journal:  Theriogenology       Date:  1975-02       Impact factor: 2.740

2.  The effect of HCG on duration of oestrus, ovulation time and fertility in mares.

Authors:  J L Voss; J J Sullivan; B W Pickett; W G Parker; L D Burwash; L L Larson
Journal:  J Reprod Fertil Suppl       Date:  1975-10

3.  Effect of dose of GnRH analog on ovulation in mares.

Authors:  E L Squires; D M Moran; M E Farlin; D J Jasko; T J Keefe; S A Meyers; E Figueiredo; P M McCue; W Jochle
Journal:  Theriogenology       Date:  1994-02-02       Impact factor: 2.740

4.  Alternative solutions to hCG induction of ovulation in the mare.

Authors:  G Duchamp; B Bour; Y Combarnous; E Palmer
Journal:  J Reprod Fertil Suppl       Date:  1987

5.  Characteristics of estrus, diestrus, and ovulation in mares and effects of season and nursing.

Authors:  O J Ginther; H L Whitmore; E L Squires
Journal:  Am J Vet Res       Date:  1972-10       Impact factor: 1.156

6.  Efficacy of human chorionic gonadotrophin and gonadotrophin releasing hormone for hastening ovulation in thoroughbred mares.

Authors:  T H Michel; P D Rossdale; R S Cash
Journal:  Equine Vet J       Date:  1986-11       Impact factor: 2.888

7.  Advancing the time of ovulation in the mare with a short-term implant releasing the GnRH analogue deslorelin.

Authors:  C Meinert; J F Silva; I Kroetz; E Klug; T E Trigg; H O Hoppen; W Jöchle
Journal:  Equine Vet J       Date:  1993-01       Impact factor: 2.888

8.  Predictable ovulation in mares treated with an implant of the GnRH analogue deslorelin.

Authors:  A O McKinnon; A M Nobelius; S T del Marmol Figueroa; J Skidmore; J R Vasey; T E Trigg
Journal:  Equine Vet J       Date:  1993-07       Impact factor: 2.888

9.  Relationship between condition score, physical measurements and body fat percentage in mares.

Authors:  D R Henneke; G D Potter; J L Kreider; B F Yeates
Journal:  Equine Vet J       Date:  1983-10       Impact factor: 2.888

10.  The effects of human chorionic gonadotrophin on ovulation, length of estrus, and fertility in the mare.

Authors:  R G Loy; J P Hughes
Journal:  Cornell Vet       Date:  1966-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.